DDR1 and neoplasm: Downstream, CXCL5-triggered PI3K/AKT signaling and DDR1-dependent JNK activation converge to elevate PD-L1 expression [7], thereby reinforcing an immunosuppressive tumor microenvironment (TME) [8].